Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Vivian Weerdesteyn benoemd tot hoogleraar in Nijmegen
apr 2021 | Bewegingsstoornissen, Neuro-vasculair